sublayersublayer
sublayersublayer

Summit Overview

The European Risk Summit which was hosted by the Irish Medicines Board, King’s Centre for Risk Management and the Nickel Institute at Trinity College Dublin (11-12 June 2013), brought renewed focus to the issue of evidence and risk-based rulemaking, and highlighted the critical role that science plays in policy formation at EU level. The purpose of the Risk Summit was to discuss the advantages of [...]

[ Read More]

PANEL CHAIRS

Professor Ragnar Löfstedt

Mr Pat O’Mahony

Dr Kevin Bradley

sublayer

Professor Ragnar Löfstedt,
Director,
King’s Centre for Risk Management

Ragnar E. Löfstedt is Professor of Risk Management and the Director of King’s Centre of Risk Management, King’s College London, UK where he teaches and conducts research on risk communication and management... [Read More]

sublayer

Pat O’Mahony,
Chief Executive,
Irish Medicines Board

Having spent a number of years in private practice and as technical manager in the pharmaceutical industry in Ireland and the UK, Mr Pat O’Mahony, M.V.B., M.V.M., A.M.D., M.B.A., M.R.C.V.S. worked in public health... [Read more]

sublayer

Dr Kevin Bradley,
President,
Nickel Institute

Dr Kevin Bradley is currently President of the Nickel Institute, the global representative body of the nickel metal and mining industry. The institute has 26 member companies including the top five multi-national mining conglomerates... [Read More]

Speaker Biographies

David B. Fischer – Senior Director, American Chemistry Council

David B. Fischer has been with the American Chemistry Council (ACC) for nearly 15 years.  He served as an Assistant General Counsel until 2010 at which time he was asked to co-manage ACC’s Chemical Products and Technology Divisions and to lead a practice area that includes numerous self-funded groups.  From [...]